Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 11 Aug 23 EFFECT Notice of effectiveness
- 10 Aug 23 424B3 Prospectus supplement
- 10 Aug 23 424B3 Prospectus supplement
- 3 Aug 23 POS AM Prospectus update (post-effective amendment)
- 24 Jul 23 POS AM Prospectus update (post-effective amendment)
- 17 Mar 23 424B3 Prospectus supplement
- 2 Mar 23 EFFECT Notice of effectiveness
- 1 Mar 23 424B3 Prospectus supplement
- 14 Feb 23 S-1/A IPO registration (amended)
- 31 Jan 23 S-1/A IPO registration (amended)
- 4 Jan 23 S-1/A IPO registration (amended)
-
14 Dec 22 S-1 IPO registration
PKBO similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 and related prospectus of our report dated June 17, 2022, with respect to the carve-out consolidated financial statements of Peak Bio Co., Ltd. as of December 31, 2021 and 2020 and for each of the two years in the period ended December 31, 2021 (which report includes an explanatory paragraph regarding the existence of substantial doubt about the Company’s ability to continue as a going concern), and to the reference to us under the heading “Experts” in the prospectus which is part of this Registration Statement.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
December 14, 2022